Cell collection study fuels Next-Gen cancer therapies
NCT ID NCT00068003
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 26 times
Summary
This study gathers white blood cells and tumor samples from up to 7,000 cancer patients and healthy volunteers to help scientists grow powerful anti-cancer cells in the lab. The cells are used to create experimental treatments for cancers like melanoma, lung, and breast cancer. Participants must already qualify for an NCI Surgery Branch treatment protocol. The goal is to advance research, not to directly treat participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.